Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1111 of 5804
-
New blood test could speed up TB diagnosis
Diagnosis Recruiting nowTuberculosis (TB) is one of the leading causes of infectious disease worldwide. The diagnosis of TB typically relies on microbiological evidence of the presence of Mycobacterium tuberculosis (MTB) or histological features of the host immune response to MTB in the infected organs.…
Sponsor: Chinese University of Hong Kong • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
Brain scans reveal how ADHD meds work in kids with autism
Symptom relief Recruiting nowThe investigators are conducting a 10-week brain imaging and medication study. They are doing the research to study the response of Attention-Deficit/ Hyperactivity Disorder (ADHD) in youth with Autism Spectrum Disorder (ASD) on extended-release formulation of mixed amphetamine s…
Phase: PHASE4 • Sponsor: Gagan Joshi • Aim: Symptom relief
Last updated Jun 27, 2026 09:10 UTC
-
Zapping liver cancer: electric pulses target tumors, spare healthy tissue
Disease control Not yet recruitingProcedural data will be recorded from patients with liver lesions from hepatocellular cancer who have been assessed by an appropriately constituted MDT (or equivalent) as appropriate to receive irreversible electroporation
Phase: NA • Sponsor: Angiodynamics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Balloon vs. stent: new trial tests which is better for Rock-Hard arteries
Disease control Recruiting nowThe goal of this clinical trial is to learn if the short and long term effect of drug coated balloon (DCB) is non-inferior to drug eluting stent (DES) in patients with severe coronary calcification after optimal calcium modification assessed by quantitative flow ratio (QFR). The …
Phase: NA • Sponsor: Shanghai Zhongshan Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
AI reads faces to predict delirium before it strikes
Knowledge-focused Not yet recruitingDelirium has a high incidence rate and significantly affects patient prognosis. Diagnosis often relies on manual assessment, which is subject to strong subjectivity, high rates of missed diagnosis, and poor stability. This study employs non-contact identification technology based…
Sponsor: Ruijin Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:10 UTC
-
Robot suits and VR goggles: the new hope for stroke recovery?
Symptom relief Recruiting now* Objective assessment of clinical symptoms, mobility and quality of life changes resulting from stroke and determination of changes resulting from therapies. * Assessment of the rehabilitation effectiveness of traditional treadmill training. * Assessment of the rehabilitation ef…
Phase: NA • Sponsor: Somogy Megyei Kaposi Mór Teaching Hospital • Aim: Symptom relief
Last updated Jul 25, 2026 00:00 UTC
-
Shocking new hope for stroke survivors: brain zaps plus rehab may restore movement
Symptom relief Not yet recruitingIschemic stroke is a leading cause of long-term motor disability, frequently resulting in hemiplegia and limitations in daily activities and quality of life. Motor rehabilitation is a fundamental component of post-stroke care across all stages of recovery; however, functional out…
Phase: NA • Sponsor: Hanoi Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 09:03 UTC
-
Heart attack drug aims to save tiny vessels
Disease control Recruiting nowThis is a Phase IIb, multicentric, prospective, randomized (1:1 ratio), open label, and no profit study, with the aim of evaluating the efficacy of late INa current inhibition to improve coronary microcirculation in patients presenting with acute myocardial infarction and multive…
Phase: PHASE2, PHASE3 • Sponsor: Federico II University • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New eczema drug GS101 takes on dupixent in major trial
Disease control Not yet recruitingThis is a a multicenter, randomized, double-blinded, parallel, positive-controlled, Phase III comparative study to evaluate GS101 Injection versus Dupixent® in participants with moderate-to-severe atopic dermatitis. A total of 572 subjects are planned to be included and randomize…
Phase: PHASE3 • Sponsor: Jiangsu Genscend Biopharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC
-
Hypnosis and VR tested to calm leukemia Patients' fears
Symptom relief Not yet recruitingThis is a pilot study comparing 3 arms (standard care with hypnosis / standard care with virtual reality / standard care alone), aimed at measuring the effect on anxiety during the induction treatment. Acute myeloid leukemia is considered an oncological emergency that requires ch…
Phase: NA • Sponsor: University Hospital, Toulouse • Aim: Symptom relief
Last updated Jun 27, 2026 09:01 UTC
-
Could a daily pill slow kidney failure in fatty liver patients?
Disease control Not yet recruitingThis project aims to investigate how Chronic Kidney Disease (CKD) develops and progresses in patients who also have Non-Alcoholic Fatty Liver Disease (NAFLD) and to evaluate whether oral semaglutide (a GLP-1 receptor agonist) can slow or prevent this progression. NAFLD and CKD f…
Phase: NA • Sponsor: Institute of Liver and Biliary Sciences, India • Aim: Disease control
Last updated Jun 27, 2026 09:02 UTC
-
New cocktail of four drugs takes on advanced colorectal cancer
Disease control Not yet recruitingA single-arm, open-label clinical study of irinotecan liposome combined with capecitabine, bevacizumab and camrelizumab as second-line or above treatment for patients with metastatic colorectal cancer, aiming to evaluate the efficacy and safety of irinotecan liposome combined wit…
Phase: PHASE2 • Sponsor: The Fourth Affiliated Hospital of Zhejiang University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
AI and wearables join forces to fight muscle loss in seniors
Knowledge-focused OngoingSarcopenia, the age-related decline in muscle mass and function, is a major contributor to frailty, disability, and mortality in older adults. Current diagnostic tools assess muscle quantity or function separately and lack predictive biomarkers, limiting early detection and perso…
Phase: NA • Sponsor: Tel Aviv University • Aim: Knowledge-focused
Last updated Jun 27, 2026 09:07 UTC
-
Double attack on tumors: freeze then irradiate shows promise in early trial
Disease control Not yet recruitingThis open-label, randomized Phase II trial evaluates whether sequential iodine-125 seed implantation followed by cryoablation improves local tumor control versus single-modality local therapy (125I seeds alone or cryoablation alone) in unresectable solid tumors. The study is bas…
Phase: PHASE2 • Sponsor: Li Min • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Gene therapy shot around the eye aims to reduce bulging in thyroid eye disease
Disease control Not yet recruitingThe goal of this study is to evaluate the safety, tolerability, and efficacy of KRIYA-586 (VV-14305) in treating thyroid eye disease (TED).
Phase: PHASE1, PHASE2 • Sponsor: Kriya Therapeutics, Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Could a single dose of ketamine keep sickle cell patients out of the hospital?
Symptom relief Not yet recruitingThe goal of this clinical trial is to learn if the use of early ketamine decreases the chance of admission to the hospital in patients with sickle cell disease presenting with pain. The main questions this study aims to answer are: * Does ketamine given within 1 hour of acute c…
Phase: PHASE3 • Sponsor: Boston Children's Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
New eczema pill shows promise in Mid-Stage trial
Symptom relief Recruiting nowThe main purpose of this study is to see how well different doses of soquelitinib work in participants with atopic dermatitis (AD) as compared to a placebo (pill with no medicine in it). To check this, the study doctors will examine participants' skin regularly to track how their…
Phase: PHASE2 • Sponsor: Corvus Pharmaceuticals, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 09:11 UTC
-
MRI may spare liver patients from painful scope procedure
Diagnosis Not yet recruitingBackground: Chronic hepatitis B (CHB)-related cirrhosis is a common cause of portal hypertension, which leads to the development of gastroesophageal varices (EGVs). High-risk varices (HRV) are associated with a higher risk of bleeding and require timely interventions. Endoscopy …
Sponsor: Beijing Friendship Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 09:10 UTC
-
New hope for Hard-to-Treat seizures: cenobamate under study
Disease control ENROLLING_BY_INVITATIONOver the last decades, multiple neuronal autoantibodies directed against intracellular or cell-surface antigens have been identified in association with epilepsy and encephalopathy. In some patients with immune-mediated brain disorders, seizures persist and become chronic despite…
Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
New endoscopic drainage may spare elderly patients from gallbladder surgery
Disease control Recruiting nowAcute cholecystitis is common in elderly patients and becomes more frequent with increasing age. Standard treatment is laparoscopic cholecystectomy (LCC), but operative treatment may be associated with increased risk in older patients with substantial comorbidity or reduced toler…
Phase: NA • Sponsor: Oulu University Hospital • Aim: Disease control
Last updated Jul 04, 2026 00:00 UTC